{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:21:05Z","timestamp":1784949665380,"version":"3.55.0"},"publisher-location":"Dordrecht","reference-count":189,"publisher":"Springer Netherlands","isbn-type":[{"value":"9789400728684","type":"print"},{"value":"9789400728691","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T00:00:00Z","timestamp":1324512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-94-007-2869-1_16","type":"book-chapter","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T21:02:49Z","timestamp":1331154169000},"page":"347-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Iatrogenic Mitochondriopathies: A Recent Lesson from Nucleoside\/Nucleotide Reverse Transcriptase Inhibitors"],"prefix":"10.1007","author":[{"given":"George P. H.","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,22]]},"reference":[{"issue":"3","key":"16_CR1_16","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1600-6143.2005.00691.x","volume":"5","author":"GL Adani","year":"2005","unstructured":"Adani GL, Baccarani U, Risaliti A, Bresadola F, Della Rocca G, Viale P (2005) Rhabdomyolysis due to Lamivudine administration in a liver transplant recipient. Am J Transplant 5(3):634","journal-title":"Am J Transplant"},{"issue":"10","key":"16_CR2_16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1089\/aid.2008.0045","volume":"24","author":"JS Affandi","year":"2008","unstructured":"Affandi JS, Price P, Imran D, Yunihastuti E, Djauzi S, Cherry CL (2008) Can we predict neuropathy risk before stavudine prescription in a resource-limited setting? AIDS Res Hum Retroviruses 24(10):1281\u20131284","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"16_CR3_16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jac\/44.1.137","volume":"44","author":"B Allaouchiche","year":"1999","unstructured":"Allaouchiche B, Duflo F, Cotte L, Mathon L, Chassard D (1999) Acute pancreatitis with severe lactic acidosis in an HIV infected patient on didanosine therapy. J Antimicrob Chemother 44(1):137\u2013138","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"16_CR4_16","first-page":"341","volume":"4","author":"AS Al-Madhoun","year":"2004","unstructured":"Al-Madhoun AS, Tjarks W, Eriksson S (2004) The role of thymidine kinases in the activation of pyrimidine nucleoside analogues. Mini Rev Med Chem 4(4):341\u2013350","journal-title":"Mini Rev Med Chem"},{"issue":"16","key":"16_CR5_16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.2174\/0929867054546663","volume":"12","author":"DE Amacher","year":"2005","unstructured":"Amacher DE (2005) Drug-associated mitochondrial toxicity and its detection. Curr Med Chem 12(16):1829\u20131839","journal-title":"Curr Med Chem"},{"issue":"46","key":"16_CR6_16","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.3748\/wjg.13.6150","volume":"13","author":"DN Amarapurkar","year":"2007","unstructured":"Amarapurkar DN (2007) Telbivudine: a new treatment for chronic hepatitis B. World J Gastroenterol 13(46):6150\u20136155","journal-title":"World J Gastroenterol"},{"issue":"15","key":"16_CR7_16","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1097\/00002030-200310170-00003","volume":"17","author":"PL Anderson","year":"2003","unstructured":"Anderson PL, Kakuda TN, Kawle S, Fletcher CV (2003) Antiviral dynamics and sex differences of zidovudine and lamivudine triphosphate concentrations in HIV-infected individuals. AIDS 17(15):2159\u20132168","journal-title":"AIDS"},{"issue":"5","key":"16_CR8_16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1086\/381678","volume":"38","author":"PL Anderson","year":"2004","unstructured":"Anderson PL, Kakuda TN, Lichtenstein KA (2004) The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities. Clin Infect Dis 38(5):743\u2013753","journal-title":"Clin Infect Dis"},{"issue":"2","key":"16_CR9_16","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/0006-291X(92)91114-6","volume":"188","author":"ES Arn\u00e9r","year":"1992","unstructured":"Arn\u00e9r ES, Spasokoukotskaja T, Eriksson S (1992) Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem Biophys Res Commun 188(2):712\u2013718","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"16_CR10_16","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1128\/AAC.01659-08","volume":"53","author":"CM Bailey","year":"2009","unstructured":"Bailey CM, Kasiviswanathan R, Copeland WC, Anderson KS (2009) R964C mutation of DNA polymerase gamma imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity. Antimicrob Agents Chemother 53(6):2610\u20132612","journal-title":"Antimicrob Agents Chemother"},{"issue":"16","key":"16_CR11_16","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1074\/jbc.M414337200","volume":"280","author":"SA Baldwin","year":"2005","unstructured":"Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, Ritzel MW, Cass CE, Young JD (2005) Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 280(16):15880\u201315887","journal-title":"J Biol Chem"},{"issue":"2","key":"16_CR12_16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF01880662","volume":"16","author":"J Balzarini","year":"1994","unstructured":"Balzarini J (1994) Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives. Pharm World Sci 16(2):113\u2013126","journal-title":"Pharm World Sci"},{"issue":"11","key":"16_CR13_16","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1016\/S0021-9258(18)83322-1","volume":"264","author":"J Balzarini","year":"1989","unstructured":"Balzarini J, Herdewijn P, De Clercq E (1989) Differential patterns of intracellular metabolism of 2\u2032,3\u2032-didehydro-2\u2032,3\u2032-dideoxythymidine (d4T) and 3\u2032-azido-2\u2032,3\u2032-dideoxythymidine (AZT), two potent anti-HIV compounds. J Biol Chem 264(11):6127\u20136133","journal-title":"J Biol Chem"},{"issue":"1","key":"16_CR14_16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.qai.0000174649.51084.46","volume":"40","author":"F Bani-Sadr","year":"2005","unstructured":"Bani-Sadr F, Carrat F, Pol S, Hor R, Rosenthal E, Goujard C, Morand P, Lunel-Fabiani F, Salmon-Ceron D, Piroth L, Pialoux G, Bentata M, Cacoub P, Perronne C, ANRS Hc02-Ribavic Study Team (2005) Risk factors for symptomatic mitochondrial toxicity in HIV\/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. J Acquir Immune Defic Syndr 40(1):47\u201352","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"16_CR15_16","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/0006-2952(94)90564-9","volume":"48","author":"M Barile","year":"1994","unstructured":"Barile M, Valenti D, Hobbs GA, Abruzzese MF, Keilbaugh SA, Passarella S, Quagliariello E, Simpson MV (1994) Mechanisms of toxicity of 3\u2032-azido-3\u2032-deoxythymidine. Its interaction with adenylate kinase. Biochem Pharmacol 48(7):1405\u20131412","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"16_CR16_16","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0006-2952(96)00831-3","volume":"53","author":"M Barile","year":"1997","unstructured":"Barile M, Valenti D, Passarella S, Quagliariello E (1997) 3\u2032-Azido-3\u2032-deoxythmidine uptake into isolated rat liver mitochondria and impairment of ADP\/ATP translocator. Biochem Pharmacol 53(7):913\u2013920","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"16_CR17_16","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1097\/00002030-199408000-00002","volume":"8","author":"M Barry","year":"1994","unstructured":"Barry M, Wild M, Veal G, Back D, Breckenridge A, Fox R, Beeching N, Nye F, Carey P, Timmins D (1994) Zidovudine phosphorylation in HIV infected patients and seronegative volunteers. AIDS 8(8):F1\u2013F5","journal-title":"AIDS"},{"issue":"2","key":"16_CR18_16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/00042560-200010010-00009","volume":"25","author":"H Behbahani","year":"2000","unstructured":"Behbahani H, Landay A, Patterson BK, Jones P, Pottage J, Agnoli M, Andersson J, Spetz AL (2000) Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy. J Acquir Immune Defic Syndr 25(2):150\u2013156","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"16_CR19_16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0022-510X(97)05376-8","volume":"149","author":"E Benbrik","year":"1997","unstructured":"Benbrik E, Chariot P, Bonavaud S, Ammi-Sa\u00efd M, Frisdal E, Rey C, Gherardi R, Barlovatz-Meimon G (1997) Cellular and mitochondrial toxicity of ziduvodine (AZT), didanosine(ddl) and zalcitabine(ddC) on cultured human cells. J Neurol Sci 149(1):19\u201325","journal-title":"J Neurol Sci"},{"issue":"3","key":"16_CR20_16","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1128\/AAC.46.5.1610-1613.2002","volume":"46","author":"G Birkus","year":"2002","unstructured":"Birkus G, Hajek M, Kramata P, Votruba I, Holy A, Otova B (2002) Tenofovir diphosphate is a poor substrate and a weak inhibitor of rat DNA polymerases alpha, delta, and epsilon. Antimicrob Agents Chemother 46(3):1610\u20131613","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"16_CR21_16","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1046\/j.1365-2893.2003.00399.x","volume":"10","author":"G Birkus","year":"2003","unstructured":"Birkus G, Gibbs CS, Cihlar T (2003) Comparative effects of adefovir and selected nucleoside inhibitors of hepatitis B virus DNA polymerase on mitochondrial DNA in liver and skeletal muscle cells. J Viral Hepat 10(1):50\u201354","journal-title":"J Viral Hepat"},{"issue":"4","key":"16_CR22_16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2796.1994.tb01088.x","volume":"235","author":"F Bissuel","year":"1994","unstructured":"Bissuel F, Bruneel F, Habersetzer F, Chassard D, Cotte L, Chevallier M, Bernuau J, Lucet JC, Trepo C (1994) Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J Intern Med 235(4):367\u2013372","journal-title":"J Intern Med"},{"issue":"9184","key":"16_CR23_16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","volume":"354","author":"S Blanche","year":"1999","unstructured":"Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, Ciraru-Vigneron N, Lacroix C, Rouzioux C, Mandelbrot L, Desguerre I, R\u00f6tig A, Mayaux MJ, Delfraissy JF (1999) Persistant mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 354(9184):1084\u20131089","journal-title":"Lancet"},{"issue":"2","key":"16_CR24_16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1086\/518976","volume":"45","author":"MG Bolhaar","year":"2007","unstructured":"Bolhaar MG, Karstaedt AS (2007) A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa. Clin Infect Dis 45(2):254\u2013260","journal-title":"Clin Infect Dis"},{"issue":"14","key":"16_CR25_16","doi-asserted-by":"publisher","first-page":"7887","DOI":"10.1074\/jbc.271.14.7887","volume":"271","author":"J Bourdais","year":"1996","unstructured":"Bourdais J, Biondi R, Sarfati S, Guerreiro C, Lascu I, Janin J, V\u00e9ron M (1996) Cellular phosphorylation of anti-HIV nucleosides. J Biol Chem 271(14):7887\u20137890","journal-title":"J Biol Chem"},{"issue":"5","key":"16_CR26_16","first-page":"297","volume":"28","author":"J Bremer","year":"1990","unstructured":"Bremer J (1990) The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem 28(5):297\u2013301","journal-title":"J Clin Chem Clin Biochem"},{"issue":"8","key":"16_CR27_16","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.1074\/jbc.274.8.4620","volume":"274","author":"EG Bridges","year":"1999","unstructured":"Bridges EG, Jiang Z, Cheng YC (1999) Characterization of a dCTP transport activity reconstituted from human mitochondria. J Biol Chem 274(8):4620\u20134625","journal-title":"J Biol Chem"},{"key":"16_CR28_16","first-page":"141","volume":"1","author":"K Brinkman","year":"1999","unstructured":"Brinkman K, ter Hofstede HJ (1999) Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: lactic acidosis, risk factors and therapeutic options. AIDS Rev 1:141\u2013148","journal-title":"AIDS Rev"},{"issue":"7","key":"16_CR29_16","first-page":"344","volume":"13","author":"AA Butt","year":"2003","unstructured":"Butt AA (2003) Fatal lactic acidosis and pancreatitis associated with ribavirin and didanosine therapy. AIDS Read 13(7):344\u2013348","journal-title":"AIDS Read"},{"issue":"2","key":"16_CR30_16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1001\/jama.288.2.207","volume":"288","author":"A Carr","year":"2002","unstructured":"Carr A, Workman C, Smith DE, Hoy J, Hudson J, Doong N, Martin A, Amin J, Freund J, Law M, Cooper DA, Mitochondrial Toxicity (MITOX) Study Group (2002) Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA 288(2):207\u2013215","journal-title":"JAMA"},{"issue":"Pt 4","key":"16_CR31_16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/brain\/119.4.1357","volume":"119","author":"J Casademont","year":"1996","unstructured":"Casademont J, Barrientos A, Grau JM, Pedrol E, Estivill X, Urbano-Marquez A, Nunes V (1996) The effect of zidovudine on skeletal muscle mtDNA in HIV-1 infected patients with mild or no muscle dysfunction. Brain 119(Pt 4):1357\u20131364","journal-title":"Brain"},{"issue":"3","key":"16_CR32_16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00002030-200002180-00022","volume":"14","author":"A Cepeda","year":"2000","unstructured":"Cepeda A, Wilks D (2000) Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection. AIDS 14(3):332\u2013333","journal-title":"AIDS"},{"issue":"1","key":"16_CR33_16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0168-8278(99)80020-8","volume":"30","author":"P Chariot","year":"1999","unstructured":"Chariot P, Drogou I, de Lacroix-Szmania I, Eliezer-Vanerot MC, Chazaud B, Lombes A, Schaeffer A, Zafrani ES (1999) Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion. J Hepatol 30(1):156\u2013160","journal-title":"J Hepatol"},{"issue":"2","key":"16_CR34_16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0006-2952(00)00334-8","volume":"60","author":"R Chen","year":"2000","unstructured":"Chen R, Nelson JA (2000) Role of organic cation transporters in the renal secretion of nucleosides. Biochem Pharmacol 60(2):215\u2013219","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"16_CR35_16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-200207010-00002","volume":"30","author":"CL Cherry","year":"2002","unstructured":"Cherry CL, Gahan ME, McArthur JC, Lewin SR, Hoy JF, Wesselingh SL (2002) Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat. J Acquir Immune Defic Syndr 30(3):271\u2013277","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"16_CR36_16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S1386-6532(02)00118-X","volume":"26","author":"CL Cherry","year":"2003","unstructured":"Cherry CL, McArthur JC, Hoy JF, Wesselingh SL (2003) Nucleoside analogues and neuropathy in the era of HAART. J Clin Virol 26(2):195\u2013207","journal-title":"J Clin Virol"},{"issue":"4","key":"16_CR37_16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/01.qai.0000224974.67962.ce","volume":"42","author":"CL Cherry","year":"2006","unstructured":"Cherry CL, Nolan D, James IR, McKinnon EJ, Mallal SA, Gahan ME, Lal L, McArthur JC, Wesselingh SL (2006) Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals. JAcquir Immune Defic Syndr 42(4):435\u2013440","journal-title":"JAcquir Immune Defic Syndr"},{"issue":"2","key":"16_CR38_16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/AAC.01215-07","volume":"52","author":"T Cihlar","year":"2008","unstructured":"Cihlar T, Ray AS, Boojamra CG, Zhang L, Hui H, Laflamme G, Vela JE, Grant D, Chen J, Myrick F, White KL, Gao Y, Lin KY, Douglas JL, Parkin NT, Carey A, Pakdaman R, Mackman RL (2008) Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant variants of human immunodeficiency virus type 1, and its orally bioavailable phosphonoamidate prodrug, GS-9131. Antimicrob Agents Chemother 52(2):655\u2013665","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"16_CR39_16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0041-008X(03)00274-6","volume":"192","author":"AC Collier","year":"2003","unstructured":"Collier AC, Helliwell RJ, Keelan JA, Paxton JW, Mitchell MD, Tingle MD (2003) 30-Azido-30-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta. Toxicol Appl Pharmacol 192(2):164\u2013173","journal-title":"Toxicol Appl Pharmacol"},{"issue":"11","key":"16_CR40_16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1056\/NEJMoa012035","volume":"346","author":"HC C\u00f4t\u00e9","year":"2002","unstructured":"C\u00f4t\u00e9 HC, Brumme ZL, Craib KJ, Alexander CS, Wynhoven B, Ting L, Wong H, Harris M, Harrigan PR, O\u2019Shaughnessy MV, Montaner JS (2002) Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 346(11):811\u2013820","journal-title":"N Engl J Med"},{"issue":"11","key":"16_CR41_16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1086\/518977","volume":"45","author":"JS Currier","year":"2007","unstructured":"Currier JS (2007) Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women. Clin Infect Dis 45(11):261\u2013262","journal-title":"Clin Infect Dis"},{"issue":"9323","key":"16_CR42_16","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/S0140-6736(02)08909-2","volume":"359","author":"F Dabis","year":"2002","unstructured":"Dabis F, Ekpini ER (2002) HIV-1\/AIDS and maternal and child health in Africa. Lancet 359(9323):2097\u20132104","journal-title":"Lancet"},{"issue":"5","key":"16_CR43_16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1567-7249(02)00003-X","volume":"1","author":"T Dagan","year":"2002","unstructured":"Dagan T, Sable C, Bray J, Gerschenson M (2002) Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence. Mitochondrion 1(5):397\u2013412","journal-title":"Mitochondrion"},{"issue":"16","key":"16_CR44_16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","volume":"322","author":"MC Dalakas","year":"1990","unstructured":"Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322(16):1098\u20131105","journal-title":"N Engl J Med"},{"issue":"6","key":"16_CR45_16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1050-1738(02)00175-5","volume":"12","author":"M Dambrova","year":"2002","unstructured":"Dambrova M, Liepinsh E, Kalvinsh I (2002) Mildronate: cardioprotective action through carnitine-lowering effect. Trends Cardiovasc Med 12(6):275\u2013279","journal-title":"Trends Cardiovasc Med"},{"issue":"12","key":"16_CR46_16","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.bcp.2004.07.039","volume":"68","author":"E De Clercq","year":"2004","unstructured":"De Clercq E (2004) Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster. Biochem Pharmacol 68(12):2301\u20132315","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"16_CR47_16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/JCI1418","volume":"102","author":"JG de la Asuncion","year":"1998","unstructured":"de la Asuncion JG, del Olmo ML, Sastre J, Millan A, Pellin A, Pallardo FV, Vina J (1998) AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins. J Clin Invest 102(1):4\u20139","journal-title":"J Clin Invest"},{"issue":"5","key":"16_CR48_16","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1073\/pnas.031430998","volume":"98","author":"V Dolce","year":"2001","unstructured":"Dolce V, Fiermonte G, Runswick MJ, Palmieri F, Walker JE (2001) The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals. Proc Natl Acad Sci USA 98(5):2284\u20132288","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"16_CR49_16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/archinte.1995.00430090111012","volume":"155","author":"R Dolin","year":"1995","unstructured":"Dolin R, Amato DA, Fischl MA, Pettinelli C, Beltangady M, Liou SH, Brown MJ, Cross AP, Hirsch MS, Hardy WD, Mildvan D, Blair DC, Powderly WG, Para MF, Fife KH, Steigbigel RT, Smaldone L, AIDS Clinical Trials Group (1995) Zidovudine compared with didanosine in patients with advanced HIV-1 infection and little or no previous experience with zidovudine. Arch Intern Med 155(9):961\u2013974","journal-title":"Arch Intern Med"},{"issue":"1","key":"16_CR50_16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0022-3476(95)70275-X","volume":"127","author":"MJ Domanski","year":"1995","unstructured":"Domanski MJ, Sloas MM, Follmann DA, Scalise PP 3rd, Tucker EE, Egan D, Pizzo PA (1995) Effect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virus. J Pediatr 127(1):137\u2013146","journal-title":"J Pediatr"},{"issue":"10","key":"16_CR51_16","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/modpathol.3800652","volume":"19","author":"JP Duong Van Huyen","year":"2006","unstructured":"Duong Van Huyen JP, Batisse D, Heudes D, Belair MF, Piketty C, Gonzalez-Canali G, Weiss L, Kazatchkine MD, Bruneval P (2006) Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients. Mod Pathol 19(10):1277\u20131288","journal-title":"Mod Pathol"},{"issue":"7","key":"16_CR52_16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/sj.bjp.0701276","volume":"121","author":"A Elimadi","year":"1997","unstructured":"Elimadi A, Morin D, Albengres E, Chauvet-Monges AM, Allain V, Crevat A, Tillement JP (1997) Differential effects of zidovudine and zidovudine triphosphate on mitochondrial permeability transition and oxidative phosphorylation. Br J Pharmacol 121(7):1295\u20131300","journal-title":"Br J Pharmacol"},{"issue":"9","key":"16_CR53_16","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1073\/pnas.96.9.4820","volume":"96","author":"LA Esposito","year":"1999","unstructured":"Esposito LA, Melov S, Panov A, Cottrell BA, Wallace DC (1999) Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 96(9):4820\u20134825","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"16_CR54_16","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1128\/AAC.41.5.1099","volume":"41","author":"MB Faletto","year":"1997","unstructured":"Faletto MB, Miller WH, Garvey EP, St Clair MH, Daluge SM, Good SS (1997) Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89. Antimicrob Agents Chemother 41(5):1099\u20131107","journal-title":"Antimicrob Agents Chemother"},{"key":"16_CR55_16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1146\/annurev.biochem.76.060305.152028","volume":"76","author":"M Falkenberg","year":"2007","unstructured":"Falkenberg M, Larsson NG, Gustafsson CM (2007) DNA replication and transcription in mammalian mitochondria. Annu Rev Biochem 76:679\u2013699","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"16_CR56_16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00002030-199702000-00008","volume":"11","author":"G Famularo","year":"1997","unstructured":"Famularo G, Moretti S, Marcellini S, Trinchieri V, Tzantzoglou S, Santini G, Longo A, De Simone C (1997) Acetyl-carnitine deficiency in AIDS patients with neurotoxicity on treatment with antiretroviral nucleoside analogues. AIDS 11(2):185\u2013190","journal-title":"AIDS"},{"issue":"2","key":"16_CR57_16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00042560-199510020-00009","volume":"10","author":"CJ Fichtenbaum","year":"1995","unstructured":"Fichtenbaum CJ, Clifford DB, Powderly WG (1995) Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 10(2):169\u2013174","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"4","key":"16_CR58_16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jhep.2009.06.011","volume":"51","author":"RD Fleischer","year":"2009","unstructured":"Fleischer RD, Lok AS (2009) Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B. J Hepatol 51(4):787\u2013791","journal-title":"J Hepatol"},{"issue":"8","key":"16_CR59_16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/j.1365-2044.2005.04208.x","volume":"60","author":"V Fodale","year":"2005","unstructured":"Fodale V, Mazzeo A, Pratic\u00f2 C, Aguennouz M, Toscano A, Santamaria LB, Vita G (2005) Fatal exacerbation of peripheral neuropathy during lamivudine therapy: evidence for iatrogenic mitochondrial damage. Anaesthesia 60(8):806\u2013810","journal-title":"Anaesthesia"},{"issue":"13","key":"16_CR60_16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1097\/00002030-200109070-00012","volume":"15","author":"A Foli","year":"2001","unstructured":"Foli A, Benvenuto F, Piccinini G, Bareggi A, Cossarizza A, Lisziewicz J, Lori F (2001) Direct analysis of mitochondrial toxicity of antiretroviral drugs. AIDS 15(13):1687\u20131694","journal-title":"AIDS"},{"issue":"9124","key":"16_CR61_16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0140-6736(05)60266-8","volume":"352","author":"B Fouty","year":"1998","unstructured":"Fouty B, Frerman F, Reves R (1998) Riboflavin to treat nucleoside analogue-induced lactic acidosis. Lancet 352(9124):291\u2013292","journal-title":"Lancet"},{"issue":"9","key":"16_CR62_16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1089\/aid.2004.20.916","volume":"20","author":"I Frank","year":"2004","unstructured":"Frank I, Bosch RJ, Fiscus S, Valentine F, Flexner C, Segal Y, Ruan P, Gulick R, Wood K, Estep S, Fox L, Nevin T, Stevens M, Eron JJ Jr, ACTG 307 Protocol Team, (2004) Activity, safety, and immunological effects of hydroxyurea added to didanosine in antiretroviral-naive and experienced HIV type 1-infected subjects: a randomized, placebo-controlled trial, ACTG 307. AIDS Res Hum Retroviruses 20(9):916\u2013926","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"16_CR63_16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/0006-291X(88)90659-6","volume":"154","author":"LW Frick","year":"1988","unstructured":"Frick LW, Nelson DJ, St Clair MH, Furman PA, Krenitsky TA (1988) Effects of 3\u2032-azido-3\u2032-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem Biophys Res Commun 154(1):124\u2013129","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"16_CR64_16","doi-asserted-by":"publisher","first-page":"8333","DOI":"10.1073\/pnas.83.21.8333","volume":"83","author":"PA Furman","year":"1986","unstructured":"Furman PA, Fyfe JA, St Clair MH, Weinhold K, Rideout JL, Freeman GA, Lehrman SN, Bolognesi DP, Broder S, Mitsuya H, Barry DW (1986) Phosphorylation of 3\u2032-azido-3\u2032-deoxythymidine and selective interaction of the 5\u2032-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA 83(21):8333\u20138337","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"16_CR65_16","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1172\/JCI116463","volume":"91","author":"WY Gao","year":"1993","unstructured":"Gao WY, Shirasaka T, Johns DG, Broder S, Mitsuya H (1993) Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. J Clin Invest 91(5):2326\u20132333","journal-title":"J Clin Invest"},{"issue":"17","key":"16_CR66_16","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1016\/S0021-9258(18)99923-0","volume":"269","author":"WY Gao","year":"1994","unstructured":"Gao WY, Agbaria R, Driscoll JS (1994) Mitsuya H. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2,3-dideoxynucleoside analogs in resting and activated human cells. J Biol Chem 269(17):12633\u201312638","journal-title":"J Biol Chem"},{"issue":"8\u20139","key":"16_CR67_16","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1081\/NCN-200027545","volume":"23","author":"N Gattermann","year":"2004","unstructured":"Gattermann N, Dadak M, Hofhaus G, Wulfert M, Berneburg M, Loeffler ML, Simmonds HA (2004) Severe impairment of nucleotide synthesisthrough inhibition of mitochondrial respiration. Nucleosides Nucleotides Nucleic Acids 23(8\u20139):1275\u20131279","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"16_CR68_16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1749-6632.2000.tb05496.x","volume":"918","author":"M Gerschenson","year":"2000","unstructured":"Gerschenson M, Poirier MC (2000) Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure. Ann N Y Acad Sci 918:269\u2013281","journal-title":"Ann N Y Acad Sci"},{"issue":"6 Pt 2","key":"16_CR69_16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/0002-9343(89)90478-6","volume":"86","author":"E Gertner","year":"1989","unstructured":"Gertner E, Thurn JR, Williams DN, Simpson M, Balfour HH Jr, Rhame F, Henry K (1989) Zidovudine-associated myopathy. Am J Med 86(6 Pt 2):814\u2013818","journal-title":"Am J Med"},{"issue":"1","key":"16_CR70_16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/00002030-199301000-00005","volume":"7","author":"MH Godfried","year":"1993","unstructured":"Godfried MH, van der Poll T, Jansen J, Romijin JA, Schattenkerk JK, Endert E, van Deventer SJ, Sauerwein HP (1993) Soluble receptors for tumour necrosis factor: a putative marker of disease progression in HIV infection. AIDS 7(1):33\u201336","journal-title":"AIDS"},{"issue":"4","key":"16_CR71_16","doi-asserted-by":"publisher","first-page":"G910","DOI":"10.1152\/ajpgi.90672.2008","volume":"296","author":"R Govindarajan","year":"2009","unstructured":"Govindarajan R, Leung GP, Zhou M, Tse CM, Wang J, Unadkat JD (2009) Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am J Physiol Gastrointest Liver Physiol 296(4):G910\u2013G922","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"16_CR72_16","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/0006-2952(95)96620-A","volume":"50","author":"NM Gray","year":"1995","unstructured":"Gray NM, Marr CL, Penn CR, Cameron JM, Bethell RC (1995) The intracellular phosphorylation of (-)-2\u2032-deoxy-3\u2032-thiacytidine (3TC) and the incorporation of 3TC 5\u2032-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase gamma. Biochem Pharmacol 50(7):1043\u20131051","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"16_CR73_16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1021\/cr040463d","volume":"106","author":"MA Graziewicz","year":"2006","unstructured":"Graziewicz MA, Longley MJ, Copeland WC (2006) DNA polymerase gamma in mitochondrial DNA replication and repair. Chem Rev 106(2):383\u2013405","journal-title":"Chem Rev"},{"issue":"8","key":"16_CR74_16","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1023\/A:1011919319810","volume":"15","author":"H Han","year":"1998","unstructured":"Han H, de Vrueh RL, Rhie JK, Covitz KM, Smith PL, Lee CP, Oh DM, Sad\u00e9e W, Amidon GL (1998) Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res 15(8):1154\u20131159","journal-title":"Pharm Res"},{"issue":"1","key":"16_CR75_16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1128\/AAC.00778-07","volume":"52","author":"JW Hanes","year":"2008","unstructured":"Hanes JW, Johnson KA (2008) Exonuclease removal of dideoxycytidine (zalcitabine) by the human mitochondrial DNA polymerase. Antimicrob Agents Chemother 52(1):253\u2013258","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"16_CR76_16","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1097\/01.aids.0000131354.14408.fb","volume":"18","author":"AM Hart","year":"2004","unstructured":"Hart AM, Wilson AD, Montovani C, Smith C, Johnson M, Terenghi G, Youle M (2004) Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS 18(11):1549\u20131560","journal-title":"AIDS"},{"issue":"2","key":"16_CR77_16","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/aid.1997.13.193","volume":"13","author":"KI Hashimoto","year":"1997","unstructured":"Hashimoto KI, Tsunoda R, Okamoto M, Shigeta S, Baba M (1997) Stavudine selectively induces apoptosis in HIV type l-infected cells. AIDS Res Hum Retroviruses 13(2):193\u2013199","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"16_CR78_16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/QAI.0b013e3181a324d6","volume":"51","author":"SL Hendrickson","year":"2009","unstructured":"Hendrickson SL, Kingsley LA, Ruiz-Pesini E, Poole JC, Jacobson LP, Palella FJ, Bream JH, Wallace DC, O\u2019Brien SJ (2009) Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy. J Acquir Immune Defic Syndr 51(2):111\u2013116","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"16_CR79_16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2165\/00003495-200060020-00015","volume":"60","author":"PS Hervey","year":"2000","unstructured":"Hervey PS, Perry CM (2000) Abacavir: a review of its clinical potential in patients with HIV infection. Drugs 60(2):447\u2013479","journal-title":"Drugs"},{"issue":"7","key":"16_CR80_16","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood.V90.7.2670","volume":"90","author":"K Hestdal","year":"1997","unstructured":"Hestdal K, Aukrust P, M\u00fcller F, Lien E, Bjerkeli V, Espevik T, Fr\u00f8land SS (1997) Dysregulation of membrane-bound tumor necrosis factor-\u03b1 and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load. Blood 90(7):2670\u20132679","journal-title":"Blood"},{"issue":"5","key":"16_CR81_16","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1517\/14656566.8.5.679","volume":"8","author":"A Hill","year":"2007","unstructured":"Hill A, Ruxrungtham K, Hanvanich M, Katlama C, Wolf E, Soriano V, Milinkovic A, Gatell J, Ribera E (2007) Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment. Expert Opin Pharmacother 8(5):679\u2013688","journal-title":"Expert Opin Pharmacother"},{"issue":"18","key":"16_CR82_16","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1097\/00002030-200212060-00009","volume":"16","author":"PG Hoggard","year":"2002","unstructured":"Hoggard PG, Kewn S, Maherbe A, Wood R, Almond LM, Sales SD, Gould J, Lou Y, De Vries C, Back DJ, Khoo SH, CHARM Study Group (2002) Time-dependent changes in HIV nucleoside analogue phosphorylation and the effect of hydroxyurea. AIDS 16(18):2439\u20132446","journal-title":"AIDS"},{"issue":"5","key":"16_CR83_16","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1128\/AAC.01432-06","volume":"51","author":"CH Hsu","year":"2007","unstructured":"Hsu CH, Hu R, Dutschman GE, Yang G, Krishnan P, Tanaka H, Baba M, Cheng YC (2007) Comparison of the phosphorylation of 4\u2032-ethynyl 2\u2032,3\u2032-dihydro-3\u2032-deoxythymidine with that of other anti-human immunodeficiency virus thymidine analogs. Antimicrob Agents Chemother 51(5):1687\u20131693","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"16_CR84_16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/01.aids.0000180786.02930.a1","volume":"19","author":"T Hulgan","year":"2005","unstructured":"Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, Shafer RW, Clifford DB, Kallianpur AR, Summar M, Canter JA (2005) Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS 19(13):1341\u20131349","journal-title":"AIDS"},{"issue":"6","key":"16_CR85_16","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1086\/528697","volume":"197","author":"T Hulgan","year":"2008","unstructured":"Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, Dub\u00e9 M, Grinspoon S, Robbins GK, Motsinger AA, Kallianpur AR, AIDS Clinical Trials Group 384 and A5005s Study Teams (2008) Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy. J Infect Dis 197(6):858\u2013866","journal-title":"J Infect Dis"},{"issue":"2","key":"16_CR86_16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/mol.106.028233","volume":"71","author":"T Imaoka","year":"2007","unstructured":"Imaoka T, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, Sugiyama Y (2007) Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol 71(2):619\u2013627","journal-title":"Mol Pharmacol"},{"issue":"6","key":"16_CR87_16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1523-1755.2004.00866.x","volume":"66","author":"H Izzedine","year":"2004","unstructured":"Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, Currie G, Brosgart CL, Westland C, Arterbrun S, Deray G, Adefovir Dipivoxil International 437 Study Group, Adefovir Dipivoxil International 438 Study Group (2004) Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies. Kidney Int 66(6):1153\u20131158","journal-title":"Kidney Int"},{"issue":"10","key":"16_CR88_16","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrneph.2009.142","volume":"5","author":"H Izzedine","year":"2009","unstructured":"Izzedine H, Harris M, Perazella MA (2009) The nephrotoxic effects of hAArT. Nat Rev Nephrol 5(10):563\u2013573","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"16_CR89_16","first-page":"291","volume":"36","author":"MA Johnson","year":"1989","unstructured":"Johnson MA, Fridland A (1989) Phosphorylation of 2\u2032,3\u2032-dideoxyinosine by cytosolic 5\u2032-nucleotidase of human lymphoid cells. Mol Pharmacol 36(2):291\u2013295","journal-title":"Mol Pharmacol"},{"issue":"17","key":"16_CR90_16","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1046\/j.1432-1327.2000.01607.x","volume":"267","author":"M Jullig","year":"2000","unstructured":"Jullig M, Eriksson S (2000) Mitochondrial and submitochondrial localization of human deoxyguanosine kinase. Eur J Biochem 267(17):5466\u20135472","journal-title":"Eur J Biochem"},{"issue":"6","key":"16_CR91_16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","volume":"22","author":"TN Kakuda","year":"2000","unstructured":"Kakuda TN (2000) Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 22(6):685\u2013708","journal-title":"Clin Ther"},{"issue":"4","key":"16_CR92_16","first-page":"436","volume":"95","author":"L Kestens","year":"1994","unstructured":"Kestens L, Vanham G, Vereecken C, Vandenbruaene M, Vercauteren G, Colebunders RL, Gigase PL (1994) Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO \u2009+ \u2009T lymphocytes during HIV-1 infection. Clin Exp Immunol 95(4):436\u2013441","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"16_CR93_16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1046\/j.1365-2125.2000.00302.x","volume":"50","author":"S Kewn","year":"2000","unstructured":"Kewn S, Hoggard PG, Sales SD, Johnson MA, Back DJ (2000) The intracellular activation of lamivudine (3TC) and determination of 2\u2032-deoxycytidine-5\u2032-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells. Br J Clin Pharmacol 50(6):597\u2013604","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"16_CR94_16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1742-7843.2006.pto_543.x","volume":"99","author":"V Klusa","year":"2006","unstructured":"Klusa V, Pupure J, Isajevs S, Rumaks J, Gordjushina V, Kratovska A, Taivans I, Svirskis S, Viksna L, Kalvinsh I (2006) Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug. Basic Clin Pharmacol Toxicol 99(4):323\u2013328","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"16_CR95_16","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1021\/bi00429a011","volume":"28","author":"TA Kunkel","year":"1989","unstructured":"Kunkel TA, Mosbaugh DW (1989) Exonucleolytic proofreading by a mammalian DNA polymerase. Biochemistry 28(3):988\u2013995","journal-title":"Biochemistry"},{"issue":"6","key":"16_CR96_16","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1074\/jbc.M307938200","volume":"279","author":"Y Lai","year":"2004","unstructured":"Lai Y, Tse CM, Unadkat JD (2004) Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. J Biol Chem 279(6):4490\u20134497","journal-title":"J Biol Chem"},{"issue":"2","key":"16_CR97_16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1124\/mol.104.007120","volume":"67","author":"W Lam","year":"2005","unstructured":"Lam W, Chen C, Ruan S, Leung CH, Cheng YC (2005) Expression of deoxynucleotide carrier is not associated with the mitochondrial DNA depletion caused by anti-HIV dideoxynucleoside analogs and mitochondrial dNTP uptake. Mol Pharmacol 67(2):408\u2013416","journal-title":"Mol Pharmacol"},{"issue":"1","key":"16_CR98_16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/art.23235","volume":"58","author":"D Lebrecht","year":"2008","unstructured":"Lebrecht D, Deveaud C, Beauvoit B, Bonnet J, Kirschner J, Walker UA (2008) Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice. Arthritis Rheum 58(1):318\u2013326","journal-title":"Arthritis Rheum"},{"issue":"10","key":"16_CR99_16","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/00002030-199710001-00003","volume":"11","author":"NP Lenzo","year":"1997","unstructured":"Lenzo NP, Garas BA, French MA (1997) Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report. AIDS 11(10):1294\u20131295","journal-title":"AIDS"},{"issue":"8","key":"16_CR100_16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1139\/y99-059","volume":"77","author":"S Leung","year":"1999","unstructured":"Leung S, Bendayan R (1999) Role of P-glycoprotein in the renal transport of dideoxynucleoside analog drugs. Can J Physiol Pharmacol 77(8):625\u2013630","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"16_CR101_16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1517\/17425255.3.5.705","volume":"3","author":"GP Leung","year":"2007","unstructured":"Leung GP, Tse CM (2007) The role of mitochondrial and plasma membrane nucleoside transporters in drug toxicity. Expert Opin Drug Metab Toxicol 3(5):705\u2013718","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"16_CR102_16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nm0595-417","volume":"1","author":"W Lewis","year":"1995","unstructured":"Lewis W, Dalakas MC (1995) Mitochondrial toxicity of antiviral drugs. Nat Med 1(5):417\u2013422","journal-title":"Nat Med"},{"issue":"4","key":"16_CR103_16","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1172\/JCI115722","volume":"89","author":"W Lewis","year":"1992","unstructured":"Lewis W, Gonzalez B, Chomyn A, Papoian T (1992) Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest 89(4):1354\u20131360","journal-title":"J Clin Invest"},{"issue":"10","key":"16_CR104_16","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nrd1201","volume":"2","author":"W Lewis","year":"2003","unstructured":"Lewis W, Day BJ, Copeland WC (2003) Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective. Nat Rev Drug Discov 2(10):812\u2013822","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"16_CR105_16","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/labinvest.3700301","volume":"85","author":"W Lewis","year":"2005","unstructured":"Lewis W, Haase CP, Miller YK, Ferguson B, Stuart T, Ludaway T, McNaught J, Russ R, Steltzer J, Santoianni R, Long R, Fiermonte G, Palmieri F (2005) Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS. Lab Invest 85(8):972\u2013981","journal-title":"Lab Invest"},{"issue":"5","key":"16_CR106_16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/01.aids.0000216367.23325.58","volume":"20","author":"W Lewis","year":"2006","unstructured":"Lewis W, Kohler JJ, Hosseini SH, Haase CP, Copeland WC, Bienstock RJ, Ludaway T, McNaught J, Russ R, Stuart T, Santoianni R (2006) Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. AIDS 20(5):675\u2013684","journal-title":"AIDS"},{"issue":"1","key":"16_CR107_16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1086\/426076","volume":"40","author":"KA Lichtenstein","year":"2005","unstructured":"Lichtenstein KA, Armon C, Baron A, Moorman AC, Wood KC, Holmberg SD, HIV Outpatient Study Investigators (2005) Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 40(1):148\u2013157","journal-title":"Clin Infect Dis"},{"issue":"26","key":"16_CR108_16","doi-asserted-by":"publisher","first-page":"23616","DOI":"10.1074\/jbc.M101114200","volume":"276","author":"SE Lim","year":"2001","unstructured":"Lim SE, Copeland WC (2001) Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J Biol Chem 276(26):23616\u201323623","journal-title":"J Biol Chem"},{"issue":"1","key":"16_CR109_16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0022-2836(03)00405-4","volume":"329","author":"SE Lim","year":"2003","unstructured":"Lim SE, Ponamarev MV, Longley MJ, Copeland WC (2003) Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs. J Mol Biol 329(1):45\u201357","journal-title":"J Mol Biol"},{"issue":"11","key":"16_CR110_16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1056\/NEJM200009143431102","volume":"343","author":"SE Lipshultz","year":"2000","unstructured":"Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, Lai WW, Moodie DS, Sopko G, McIntosh K, Colan SD (2000) Absence of cardiac toxicity of zidovudine in infants. Pediatric pulmonary and cardiac complications of vertically transmitted HIV infection study group. N Engl J Med 343(11):759\u2013766","journal-title":"N Engl J Med"},{"issue":"4","key":"16_CR111_16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/00126334-200408010-00007","volume":"36","author":"JT Lonergan","year":"2004","unstructured":"Lonergan JT, McComsey GA, Fisher RL, Shalit P, File TM Jr, Ward DJ, Williams VC, Hessenthaler SM, Lindsey L, Hernandez JE, for the ESS40010 (TARHEEL) Study Team (2004) Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir to zidovudine. J Acquir Immune Defic Syndr 36(4):935\u2013942","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"16_CR112_16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1385\/CT:4:3:217","volume":"4","author":"KC Lund","year":"2004","unstructured":"Lund KC, Wallace KB (2004) Direct, DNA pol-gamma-independent effects of nucleoside reverse transcriptase inhibitors on mitochondrial bioenergetics. Cardiovasc Toxicol 4(3):217\u2013228","journal-title":"Cardiovasc Toxicol"},{"issue":"1","key":"16_CR113_16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.taap.2007.08.015","volume":"226","author":"KC Lund","year":"2008","unstructured":"Lund KC, Wallace KB (2008) Adenosine 3\u2032,5\u2032-cyclic monophosphate (cAMP)-dependent phosphoregulation of mitochondrial complex I is inhibited by nucleoside reverse transcriptase inhibitors. Toxicol Appl Pharmacol 226(1):94\u2013106","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"16_CR114_16","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1128\/AAC.01115-08","volume":"53","author":"MD Lynx","year":"2009","unstructured":"Lynx MD, LaClair DD, McKee EE (2009) Effects of zidovudine and stavudine on mitochondrial DNA of differentiating 3 T3-F442a cells are not associated with imbalanced deoxynucleotide pools. Antimicrob Agents Chemother 53(3):1252\u20131255","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"16_CR115_16","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1128\/AAC.38.12.2743","volume":"38","author":"JL Martin","year":"1994","unstructured":"Martin JL, Brown CE, Matthews-Davis N, Reardon JE (1994) Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis. Antimicrob Agents Chemother 38(12):2743\u20132749","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"16_CR116_16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1086\/367849","volume":"72","author":"AM Martin","year":"2003","unstructured":"Martin AM, Hammond E, Nolan D, Pace C, Den Boer M, Taylor L, Moore H, Martinez OP, Christiansen FT, Mallal S (2003) Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reversetranscriptase inhibitors. Am J Hum Genet 72(3):549\u2013560","journal-title":"Am J Hum Genet"},{"issue":"2","key":"16_CR117_16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1128\/AAC.01122-07","volume":"52","author":"CE Mazzucco","year":"2008","unstructured":"Mazzucco CE, Hamatake RK, Colonno RJ, Tenney DJ (2008) Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition. Antimicrob Agents Chemother 52(2):598\u2013605","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"16_CR118_16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00126334-200309010-00006","volume":"34","author":"GA McComsey","year":"2003","unstructured":"McComsey GA, Morrow JD (2003) Lipid oxidative markers are significantly increased in lipoatrophy, but not in sustained asymptomatic hyperlactatemia. J Acquir Immune Defic Syndr 34(1):45\u201349","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"16_CR119_16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/00002030-200203080-00001","volume":"16","author":"G McComsey","year":"2002","unstructured":"McComsey G, Tan DJ, Lederman M, Wilson E, Wong LJ (2002) Analysis of mitochondrial DNA genome in the peripheral blood leukocytes of HIV-infected patients with of without lipoatrophy. AIDS 16(4):513\u2013518","journal-title":"AIDS"},{"issue":"5","key":"16_CR120_16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/00126334-200308150-00009","volume":"33","author":"G McComsey","year":"2003","unstructured":"McComsey G, Southwell H, Gripshover B, Salata R, Valdez H (2003) Effect of antioxidants on glucose metabolism and plasma lipids in HIV-infected subjects with lipoatrophy. J Acquir Immune Defic Syndr 33(5):605\u2013607","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"16_CR121_16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1086\/380790","volume":"38","author":"GA McComsey","year":"2004","unstructured":"McComsey GA, Ward DJ, Hessenthaler SM, Sension MG, Shalit P, Lonergan JT, Fisher RL, Williams VC, Hernandez JE, Trial to Assess the Regression of Hyperlactatemia and to Evaluate the Regression of Established Lipodystrophy in HIV-1-Positive Subjects (TARHEEL; ESS40010) Study Team (2004) Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study. Clin Infect Dis 38(2):263\u2013270","journal-title":"Clin Infect Dis"},{"issue":"2","key":"16_CR122_16","first-page":"181","volume":"39","author":"G McComsey","year":"2005","unstructured":"McComsey G, Bai RK, Maa JF, Seekins D, Wong LJ (2005) Extensive investigations of mitochondrial DNA genome in treated HIV-infected subjects: beyond mitochondrial DNA depletion. J Acquir Immune Defic Syndr 39(2):181\u2013188","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"16_CR123_16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1385\/CT:4:2:155","volume":"4","author":"EE McKee","year":"2004","unstructured":"McKee EE, Bentley AT, Hatch M, Gingerich J, Susan-Resiga D (2004) Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity. Cardiovasc Toxicol 4(2):155\u2013167","journal-title":"Cardiovasc Toxicol"},{"issue":"17","key":"16_CR124_16","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1056\/NEJM199510263331702","volume":"333","author":"R McKenzie","year":"1995","unstructured":"McKenzie R, Fried MW, Sallie R, Conjeevaram H, Di Bisceglie AM, Park Y, Savarese B, Kleiner D, Tsokos M, Luciano C, Pruett T, Stotka JL, Straus SE, Hoofnagle JH (1995) Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 333(17):1099\u20131105","journal-title":"N Engl J Med"},{"issue":"5","key":"16_CR125_16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/mutage\/15.5.405","volume":"15","author":"Q Meng","year":"2000","unstructured":"Meng Q, Grosovsky AJ, Shi X, Walker VE (2000) Mutagenicity and loss of heterozygosity at the APRT locus in human lymphoblastoid cells exposed to 3\u2032-azido-3\u2032-deoxythymidine. Mutagenesis 15(5):405\u2013410","journal-title":"Mutagenesis"},{"issue":"10","key":"16_CR126_16","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/0006-2952(92)90110-5","volume":"44","author":"A Merta","year":"1992","unstructured":"Merta A, Votruba I, Jindrich J, Hol\u00fd A, Cihl\u00e1r T, Rosenberg I, Otmar M, Herve TY (1992) Phosphorylation of 9-(2-phosphonomethoxyethyl)adenine and 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl)adenine by AMP(dAMP) kinase from L1210 cells. Biochem Pharmacol 44(10):2067\u20132077","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"16_CR127_16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-133-3-200008010-00010","volume":"133","author":"KD Miller","year":"2000","unstructured":"Miller KD, Cameron M, Wood LV, Dalakas MC, Kovacs JA (2000) Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med 133(3):192\u2013196","journal-title":"Ann Intern Med"},{"issue":"5","key":"16_CR128_16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1097\/00126334-200412150-00002","volume":"37","author":"O Mir\u00f3","year":"2004","unstructured":"Mir\u00f3 O, L\u00f3pez S, Rodr\u00edguez de la Concepci\u00f3n M, Mart\u00ednez E, Pedrol E, Garrabou G, Giralt M, Cardellach F, Gatell JM, Vilarroya F, Casademont J (2004) Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine. J Acquir Immune Defic Syndr 37(5):1550\u20131555","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"16_CR129_16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1006\/bbrc.1993.1800","volume":"194","author":"JS Modica-Napolitano","year":"1993","unstructured":"Modica-Napolitano JS (1993) AZT causes tissue-specific inhibition of mitochondrial bioenergetic function. Biochem Biophys Res Commun 194(1):170\u2013177","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"16_CR130_16","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1345\/aph.1D302","volume":"38","author":"KA Modrzejewski","year":"2004","unstructured":"Modrzejewski KA, Herman RA (2004) Emtricitabine: a once-daily nucleoside reverse transcriptase inhibitor. Ann Pharmacother 38(6):1006\u20131014","journal-title":"Ann Pharmacother"},{"issue":"1","key":"16_CR131_16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1086\/313594","volume":"30","author":"H Mokrzycki","year":"2000","unstructured":"Mokrzycki H, Harris C, May H, Laut J, Palmisano J (2000) Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis 30(1):198\u2013200","journal-title":"Clin Infect Dis"},{"issue":"3","key":"16_CR132_16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/00002030-200002180-00009","volume":"14","author":"RD Moore","year":"2000","unstructured":"Moore RD, Wong WM, Keruly JC, McArthur JC (2000) Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea. AIDS 14(3):273\u2013278","journal-title":"AIDS"},{"issue":"1","key":"16_CR133_16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/135965350400900108","volume":"9","author":"A Moreno","year":"2004","unstructured":"Moreno A, Quereda C, Moreno L, Perez-El\u00edas MJ, Muriel A, Casado JL, Antela A, Dronda F, Navas E, B\u00e1rcena R, Moreno S (2004) High rate of didanosine-related mitochondrial toxicity in HIV\/HCV-coinfected patients receiving ribavirin. Antivir Ther 9(1):133\u2013138","journal-title":"Antivir Ther"},{"issue":"3","key":"16_CR134_16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/15230860260196191","volume":"4","author":"S Moretti","year":"2002","unstructured":"Moretti S, Famularo G, Marcellini S, Boschini A, Santini G, Trinchieri V, Lucci L, Alesse E, De Simone C (2002) L-carnitine reduces lymphocyte apoptosis and oxidative stress in HIV-1-infected subjects treated with zidovudine and didanosine. Antioxid Redox Signal 4(3):391\u2013403","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"16_CR135_16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1042\/BJ20082427","volume":"422","author":"GW Morris","year":"2009","unstructured":"Morris GW, Iams TA, Slepchenko KG, McKee EE (2009) Origin of pyrimidine deoxyribonucleotide pools in perfused rat heart: implications for 3\u2032-azido-3\u2032-deoxythymidine-dependent cardiotoxicity. Biochem J 422(3):513\u2013520","journal-title":"Biochem J"},{"issue":"8","key":"16_CR136_16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0149-2918(00)80064-8","volume":"22","author":"G Moyle","year":"2000","unstructured":"Moyle G (2000) Clinical manifestations and management of antiretroviral nucleoside analog-related mitochondrial toxicity. Clin Ther 22(8):911\u2013936","journal-title":"Clin Ther"},{"issue":"Suppl 2","key":"16_CR137_16","doi-asserted-by":"crossref","first-page":"M47","DOI":"10.1177\/135965350501002S05","volume":"10","author":"G Moyle","year":"2005","unstructured":"Moyle G (2005) Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria. Antivir Ther 10(Suppl 2):M47\u2013M52","journal-title":"Antivir Ther"},{"issue":"10","key":"16_CR138_16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/00002030-200207050-00005","volume":"16","author":"GJ Moyle","year":"2002","unstructured":"Moyle GJ, Datta D, Mandalia S, Morlese J, Asboe D, Gazzard BG (2002) Hyperlactatemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. AIDS 16(10):1341\u20131349","journal-title":"AIDS"},{"issue":"2","key":"16_CR139_16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF00224774","volume":"64","author":"B Munch-Petersen","year":"1984","unstructured":"Munch-Petersen B (1984) Differences in the kinetic properties of thymidine kinase isoenzymes in unstimulated and phytohemagglutinin-stimulated human lymphocytes. Mol Cell Biochem 64(2):173\u2013185","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"16_CR140_16","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0005-2787(77)90152-6","volume":"478","author":"B Munch-Petersen","year":"1977","unstructured":"Munch-Petersen B, Tyrsted G (1977) Induction of thymidine kinases in phytohaemagglutinin-stimulated human lymphocytes. Biochim Biophys Acta 478(3):364\u2013375","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"16_CR141_16","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1086\/605440","volume":"49","author":"E Negredo","year":"2009","unstructured":"Negredo E, Mir\u00f3 O, Rodr\u00edguez-Santiago B, Garrabou G, Estany C, Masabeu A, Force L, Barrufet P, Cucurull J, Domingo P, Alonso-Villaverde C, Bonjoch A, Mor\u00e9n C, P\u00e9rez-Alvarez N, Clotet B, MULTINEKA Study Group (2009) Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). Clin Infect Dis 49(6):892\u2013900","journal-title":"Clin Infect Dis"},{"issue":"1","key":"16_CR142_16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.expneurol.2006.09.010","volume":"204","author":"WO Opii","year":"2007","unstructured":"Opii WO, Sultana R, Abdul HM, Ansari MA, Nath A, Butterfield DA (2007) Oxidative stress and toxicity induced by the nucleoside reverse transcriptase inhibitor (NRTI)\u20132\u2032,3\u2032-dideoxycytidine (ddC): relevance to HIV-dementia. Exp Neurol 204(1):29\u201338","journal-title":"Exp Neurol"},{"key":"16_CR143_16","first-page":"139","volume-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2008","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents (2008) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services (DHHS), Bethesda, p 139"},{"issue":"3","key":"16_CR144_16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1128\/AAC.44.3.496-503.2000","volume":"44","author":"XR Pan-Zhou","year":"2000","unstructured":"Pan-Zhou XR, Cui L, Zhou XJ, Sommadossi JP, Darley-Usmar VM (2000) Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells. Antimicrob Agents Chemother 44(3):496\u2013503","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"16_CR145_16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/00002018-200629010-00002","volume":"29","author":"AC Peltier","year":"2006","unstructured":"Peltier AC, Russell JW (2006) Advances in understanding drug-induced neuropathies. Drug Saf 29(1):23\u201330","journal-title":"Drug Saf"},{"issue":"4","key":"16_CR146_16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V80.4.995.995","volume":"80","author":"CF Perno","year":"1992","unstructured":"Perno CF, Cooney DA, Gao WY, Hao Z, Johns DG, Foli A, Hartman NR, Cali\u00f2 R, Broder S, Yarchoan R (1992) Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte\/macrophages. Blood 80(4):995\u20131003","journal-title":"Blood"},{"issue":"5","key":"16_CR147_16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/00002030-200003310-00017","volume":"14","author":"A Ronan","year":"2000","unstructured":"Ronan A, Lipman C, Johnson A, Breen RA (2000) Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals. AIDS 14(5):615\u2013616","journal-title":"AIDS"},{"issue":"Pt 3","key":"16_CR148_16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1042\/0264-6021:3440915","volume":"344","author":"L Rossi","year":"1999","unstructured":"Rossi L, Serafini S, Schiavano GF, Casabianca A, Vallanti G, Chiarantini L, Magnani M (1999) Metabolism, mitochondrial uptake and toxicity of 2\u2032,3\u2032-dideoxycytidine. Biochem J 344(Pt 3):915\u2013920","journal-title":"Biochem J"},{"issue":"6","key":"16_CR149_16","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.bcp.2004.12.010","volume":"69","author":"SN Rylova","year":"2005","unstructured":"Rylova SN, Albertioni F, Flygh G, Eriksson S (2005) Activity profiles of deoxynucleoside kinases and 5\u2032-nucleotidases in cultured adipocytes and myoblastic cells: insights into mitochondrial toxicity of nucleoside analogs. Biochem Pharmacol 69(6):951\u2013960","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"16_CR150_16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bcp.2007.03.029","volume":"74","author":"SN Rylova","year":"2007","unstructured":"Rylova SN, Mirzaee S, Albertioni F, Eriksson S (2007) Expression of deoxynucleoside kinases and 5\u2032-nucleotidases in mouse tissues: implications for mitochondrial toxicity. Biochem Pharmacol 74(1):169\u2013175","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"16_CR151_16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/carcin\/5.2.183","volume":"5","author":"S Sakamoto","year":"1984","unstructured":"Sakamoto S, Iwama T, Tsukada K, Utsunomiya J, Kawasaki T, Okamoto R (1984) Increased activity of thymidine kinase isozyme in human colon tumor. Carcinogenesis 5(2):183\u2013185","journal-title":"Carcinogenesis"},{"issue":"1","key":"16_CR152_16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1006\/taap.2001.9288","volume":"177","author":"SD Sales","year":"2001","unstructured":"Sales SD, Hoggard PG, Sunderland D, Khoo S, Hart CA, Back DJ (2001) Zidovudine phosphorylation and mitochondrial toxicity in vitro. Toxicol Appl Pharmacol 177(1):54\u201358","journal-title":"Toxicol Appl Pharmacol"},{"issue":"12","key":"16_CR153_16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1089\/aid.1996.12.1151","volume":"12","author":"DT Scadden","year":"1996","unstructured":"Scadden DT, Pickus O, Hammer SM, Stretcher B, Bresnahan J, Gere J, McGrath J, Agosti JM (1996) Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 12(12):1151\u20131159","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"10","key":"16_CR154_16","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-2346.1999.00586.x","volume":"16","author":"C Schramm","year":"1999","unstructured":"Schramm C, Wanitschke R, Galle PR (1999) Thiamine for the treatment of nucleoside analogue-induced severe lactic acidosis. Eur J Anaesthesiol 16(10):733\u2013735","journal-title":"Eur J Anaesthesiol"},{"issue":"5","key":"16_CR155_16","first-page":"773","volume":"71","author":"MC Semino-Mora","year":"1994","unstructured":"Semino-Mora MC, Leon-Monzon ME, Dalakas MC (1994) Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part II: Treatment with L-carnitine improves AZTinduced changes and prevents further destruction. Lab Invest 71(5):773\u2013781","journal-title":"Lab Invest"},{"issue":"3","key":"16_CR156_16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2353\/ajpath.2008.070613","volume":"172","author":"B Setzer","year":"2008","unstructured":"Setzer B, Lebrecht D, Walker UA (2008) Pyrimidine nucleoside depletion sensitizes to the mitochondrial hepatotoxicity of the reverse transcriptase inhibitor stavudine. Am J Pathol 172(3):681\u2013690","journal-title":"Am J Pathol"},{"issue":"4","key":"16_CR157_16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000013610","volume":"20","author":"AJ Shaer","year":"2000","unstructured":"Shaer AJ, Rastegar A (2000) Lactic acidosis in the setting of antiretroviral therapy for the acquired immunodeficiency syndrome. A case report and review of the literature. Am J Nephrol 20(4):332\u2013338","journal-title":"Am J Nephrol"},{"issue":"14","key":"16_CR158_16","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1097\/00002030-200109280-00009","volume":"15","author":"CM Shikuma","year":"2001","unstructured":"Shikuma CM, Hu N, Milne C, Yost F, Waslien C, Shimizu S, Shiramizu B (2001) Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy. AIDS 15(14):1801\u20131809","journal-title":"AIDS"},{"issue":"4","key":"16_CR159_16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00126334-200304010-00004","volume":"32","author":"B Shiramizu","year":"2003","unstructured":"Shiramizu B, Shikuma KM, Kamemoto L, Gerschenson M, Erdem G, Pinti M, Cossarizza A, Shikuma C (2003) Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving HAART during pregnancy. J Acquir Immune Defic Syndr 32(4):370\u2013374","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"16_CR160_16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0006-2952(99)00282-8","volume":"58","author":"G Skuta","year":"1999","unstructured":"Skuta G, Fischer GM, Janaky T, Kele Z, Szabo P, Tozser J, Sumegi B (1999) Molecular mechanism of the short-term cardiotoxicity caused by 2\u2032,3\u2032-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactions. Biochem Pharmacol 58(12):1915\u20131925","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"16_CR161_16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1468-1293.2007.00478.x","volume":"8","author":"K Smyth","year":"2007","unstructured":"Smyth K, Affandi JS, McArthur JC, Bowtell-Harris C, Mijch AM, Watson K, Costello K, Woolley IJ, Price P, Wesselingh SL, Cherry CL (2007) Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993\u20132006. HIV Med 8(6):367\u2013373","journal-title":"HIV Med"},{"issue":"14","key":"16_CR162_16","doi-asserted-by":"publisher","first-page":"4990","DOI":"10.1073\/pnas.0500253102","volume":"102","author":"S Song","year":"2005","unstructured":"Song S, Pursell ZF, Copeland WC, Longley MJ, Kunkel TA, Mathews CK (2005) DNA precursor asymmetries in mammalian tissue mitochondria and possible contribution to mutagenesis through reduced replication fidelity. Proc Natl Acad Sci USA 102(14):4990\u20134995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"16_CR163_16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0027-5107(99)00111-6","volume":"429","author":"HE Sussman","year":"1999","unstructured":"Sussman HE, Olivero OA, Meng Q, Pietras SM, Poirier MC, O\u2019Neill JP, Finette BA, Bauer MJ, Walker VE (1999) Genotoxicity of 3\u2032-azido-3\u2032-deoxythymidine in the human lymphoblastoid cell line, TK6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT. Mutat Res 429(2):249\u2013259","journal-title":"Mutat Res"},{"issue":"3\u20134","key":"16_CR164_16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0891-5849(98)00199-3","volume":"26","author":"E Szabados","year":"1999","unstructured":"Szabados E, Fischer GM, Toth K, Csete B, Nemeti B, Trombitas K, Habon T, Endrei D, Sumegi B (1999) Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat. Free Radic Biol Med 26(3\u20134):309\u2013317","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"16_CR165_16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/hupa.2001.25586","volume":"32","author":"N Tanji","year":"2001","unstructured":"Tanji N, Tanji K, Kambham N, Markowitz GS, Bell A, D\u2019agati VD (2001) Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Hum Pathol 32(7):734\u2013740","journal-title":"Hum Pathol"},{"key":"16_CR166_16","first-page":"58","volume":"3","author":"G Tesco","year":"1992","unstructured":"Tesco G, Latorraca S, Piersanti P, Piacentini S, Amaducci L, Sorbi S (1992) Protection from oxygen radical damage in human diploid fibroblasts by acetyl-L-carnitine. Dementia 3:58\u201360","journal-title":"Dementia"},{"issue":"5381","key":"16_CR167_16","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1126\/science.281.5381.1312","volume":"281","author":"NA Thornberry","year":"1998","unstructured":"Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281(5381):1312\u20131316","journal-title":"Science"},{"issue":"7","key":"16_CR168_16","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/0006-2952(94)90573-8","volume":"48","author":"CH Tsai","year":"1994","unstructured":"Tsai CH, Doong SL, Johns DG, Driscoll JS, Cheng YC (1994) Effect of anti-HIV 2\u2032-beta-fluoro-2\u2032,3\u2032-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production. Biochem Pharmacol 48(7):1477\u20131481","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"16_CR169_16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1590\/S1413-86702008000400001","volume":"12","author":"FF Tuon","year":"2008","unstructured":"Tuon FF, Guastini CM, Boulos MI (2008) Acute pancreatitis associated with lamivudine therapy for chronic B hepatitis. Braz J Infect Dis 12(4):263","journal-title":"Braz J Infect Dis"},{"issue":"5","key":"16_CR170_16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/01.aids.0000162335.12815.12","volume":"19","author":"O Turriziani","year":"2005","unstructured":"Turriziani O, Butera O, Gianotti N, Parisi SG, Mazzi R, Girardi E, Iaiani G, Antonelli L, Lazzarin A, Antonelli G (2005) Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients. AIDS 19(5):473\u2013479","journal-title":"AIDS"},{"issue":"4","key":"16_CR171_16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s11095-006-9196-x","volume":"24","author":"Y Uwai","year":"2007","unstructured":"Uwai Y, Ida H, Tsuji Y, Katsura T, Inui K (2007) Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). Pharm Res 24(4):811\u2013815","journal-title":"Pharm Res"},{"issue":"2\u20133","key":"16_CR172_16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0014-5793(99)00071-X","volume":"444","author":"D Valenti","year":"1999","unstructured":"Valenti D, Barile M, Quagliariello E, Passarella S (1999) Inhibition of nucleoside diphosphate kinase in rat liver mitochondria by added 3\u2032-azido-3\u2032-deoxythymidine. FEBS Lett 444(2\u20133):291\u2013295","journal-title":"FEBS Lett"},{"issue":"2","key":"16_CR173_16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0006-2952(02)01065-1","volume":"64","author":"D Valenti","year":"2002","unstructured":"Valenti D, Atlante A, Barile M, Passarella S (2002) Inhibition of phosphate transport in rat heart mitochondria by 3\u2032-azido-3\u2032-deoxythymidine due to stimulation of superoxide anion mitochondrial production. Biochem Pharmacol 64(2):201\u2013206","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"16_CR174_16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.taap.2004.03.005","volume":"199","author":"LW Velsor","year":"2004","unstructured":"Velsor LW, Kovacevic M, Goldstein M, Leitner HM, Lewis W, Day BJ (2004) Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine. Toxicol Appl Pharmacol 199(1):10\u201319","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"16_CR175_16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/135965350701200704","volume":"12","author":"N Venhoff","year":"2007","unstructured":"Venhoff N, Setzer B, Melkaoui K, Walker UA (2007) Mitochondrial toxicity of tenofovir, emtricitabine, and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Antivir Ther 12(7):1075\u20131085","journal-title":"Antivir Ther"},{"issue":"4","key":"16_CR176_16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/135965350200700402","volume":"7","author":"SM Vrouenraets","year":"2002","unstructured":"Vrouenraets SM, Treskes M, Regez RM, Troost N, Smulders YM, Weigel HM, Frissen PH, Brinkman K (2002) Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment. Antivir Ther 7(4):239\u2013244","journal-title":"Antivir Ther"},{"issue":"3","key":"16_CR177_16","first-page":"844","volume":"294","author":"S Wada","year":"2000","unstructured":"Wada S, Tsuda M, Sekine T, Cha SH, Kimura M, Kanai Y, Endou H (2000) Rat multispecifi c organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J Pharmacol Exp Ther 294(3):844\u2013849","journal-title":"J Pharmacol Exp Ther"},{"issue":"supp 2","key":"16_CR178_16","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1177\/135965350501002S13","volume":"10","author":"UA Walker","year":"2005","unstructured":"Walker UA, Venhoff N (2005) Uridine in the prevention and treatment of NRTI related mitochondrial toxicity. Antivir Ther 10(supp 2):M117\u2013M123","journal-title":"Antivir Ther"},{"issue":"16","key":"16_CR179_16","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1097\/00002030-200211080-00009","volume":"16","author":"UA Walker","year":"2002","unstructured":"Walker UA, Setzer B, Venhoff N (2002) Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. AIDS 16(16):2165\u20132173","journal-title":"AIDS"},{"issue":"2","key":"16_CR180_16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/hep.20074","volume":"39","author":"UA Walker","year":"2003","unstructured":"Walker UA, B\u00e4uerle J, Laguno M, Murillas J, Mauss S, Schmutz G, Setzer B, Miquel R, Gatell JM, Mallolas J (2003) Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine. Hepatology 39(2):311\u2013317","journal-title":"Hepatology"},{"issue":"5057","key":"16_CR181_16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1126\/science.1533953","volume":"256","author":"DC Wallace","year":"1992","unstructured":"Wallace DC (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256(5057):628\u2013632","journal-title":"Science"},{"issue":"3","key":"16_CR182_16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0014-5793(03)01181-5","volume":"554","author":"L Wang","year":"2003","unstructured":"Wang L, Eriksson S (2003) Mitochondrial deoxyguanosine kinase mutations and mitochondrial DNA depletion syndrome. FEBS Lett 554(3):319\u2013322","journal-title":"FEBS Lett"},{"issue":"12","key":"16_CR183_16","doi-asserted-by":"publisher","first-page":"8375","DOI":"10.1074\/jbc.275.12.8375","volume":"275","author":"JL Ward","year":"2000","unstructured":"Ward JL, Sherali A, Mo ZP, Tse CM (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-defi cient PK15 cells. Ent2 exhibits a low affi nity for guanosine and cytidine but a high affi nity for inosine. J Biol Chem 275(12):8375\u20138381","journal-title":"J Biol Chem"},{"issue":"2","key":"16_CR184_16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0006-291X(92)90517-O","volume":"183","author":"RJ Wiesner","year":"1992","unstructured":"Wiesner RJ, Ruegg JC, Morano I (1992) Counting target molecules by exponential polymerase chain reaction: copy number of mitochondrial DNA in rat tissues. Biochem Biophys Res Commun 183(2):553\u2013559","journal-title":"Biochem Biophys Res Commun"},{"issue":"1\u20132","key":"16_CR185_16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mrfmmm.2009.02.006","volume":"664","author":"Y Wu","year":"2009","unstructured":"Wu Y, Li N, Zhang T, Wu H, Huang C, Chen D (2009) Mitochondrial DNA base excision repair and mitochondrial DNA mutation in human hepatic HuH-7 cells exposed to stavudine. Mutat Res 664(1\u20132):28\u201338","journal-title":"Mutat Res"},{"issue":"1","key":"16_CR186_16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1128\/AAC.43.1.190","volume":"43","author":"G Yamanaka","year":"1999","unstructured":"Yamanaka G, Wilson T, Innaimo S, Bisacchi GS, Egli P, Rinehart JK, Zahler R, Colonno RJ (1999) Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus. Antimicrob Agents Chemother 43(1):190\u2013193","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"16_CR187_16","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1086\/513872","volume":"195","author":"H Yamanaka","year":"2007","unstructured":"Yamanaka H, Gatanaga H, Kosalaraksa P, Matsuoka-Aizawa S, Takahashi T, Kimura S, Oka S (2007) Novel mutation of human DNA polymerase gamma associated with mitochondrial toxicity induced by anti-HIV treatment. J Infect Dis 195(10):1419\u20131425","journal-title":"J Infect Dis"},{"issue":"Pt10","key":"16_CR188_16","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/brain\/awh259","volume":"127","author":"M Zeviani","year":"2004","unstructured":"Zeviani M, Di Donato S (2004) Mitochondrial disorders. Brain 127(Pt10):2153\u20132172","journal-title":"Brain"},{"issue":"22","key":"16_CR189_16","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.3748\/wjg.14.3549","volume":"14","author":"XS Zhang","year":"2008","unstructured":"Zhang XS, Jin R, Zhang SB, Tao ML (2008) Clinical features of adverse reactions associated with telbivudine. World J Gastroenterol 14(22):3549\u20133553","journal-title":"World J Gastroenterol"}],"container-title":["Advances in Experimental Medicine and Biology","Advances in Mitochondrial Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-94-007-2869-1_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T00:10:40Z","timestamp":1676765440000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-94-007-2869-1_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,22]]},"ISBN":["9789400728684","9789400728691"],"references-count":189,"URL":"https:\/\/doi.org\/10.1007\/978-94-007-2869-1_16","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12,22]]},"assertion":[{"value":"22 December 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}